161 related articles for article (PubMed ID: 19217351)
1. Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency.
Cuvelier GD; Schultz KR; Davis J; Hirschfeld AF; Junker AK; Tan R; Turvey SE
Clin Immunol; 2009 May; 131(2):179-88. PubMed ID: 19217351
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
[TBL] [Abstract][Full Text] [Related]
3. A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD).
Dinardo L; Brown V; Perez E; Bunin N; Sullivan KE
Pediatr Transplant; 2012 Feb; 16(1):63-72. PubMed ID: 22093026
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for lymphoproliferative disease prior to haematopoietic stem cell transplantation for X-linked severe combined immunodeficiency.
Trahair TN; Wainstein B; Manton N; Bourne AJ; Ziegler JB; Rice M; Russell SJ
Pediatr Blood Cancer; 2008 Feb; 50(2):366-9. PubMed ID: 16732583
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
Dvorak CC; Cowan MJ
Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
7. Case Report: A Novel IL2RG Frame-Restoring Rescue Mutation Mimics Early T Cell Engraftment Following Haploidentical Hematopoietic Stem Cell Transplantation in a Patient With X-SCID.
Steininger J; Leiss-Piller A; Geier CB; Rossmanith R; Elfeky R; Bra D; Pichler H; Lawitschka A; Zubarovskaya N; Artacker G; Matthes-Leodolter S; Eibl MM; Wolf HM
Front Immunol; 2021; 12():644687. PubMed ID: 33959125
[TBL] [Abstract][Full Text] [Related]
8. The evolution of gene therapy in X-linked severe combined immunodeficiency.
Rans TS; England R
Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
[TBL] [Abstract][Full Text] [Related]
9. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1.
Touzot F; Moshous D; Creidy R; Neven B; Frange P; Cros G; Caccavelli L; Blondeau J; Magnani A; Luby JM; Ternaux B; Picard C; Blanche S; Fischer A; Hacein-Bey-Abina S; Cavazzana M
Blood; 2015 Jun; 125(23):3563-9. PubMed ID: 25869287
[TBL] [Abstract][Full Text] [Related]
10. A tale of two SCIDs.
Shaw KL; Kohn DB
Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency: a national surveillance study.
Yee A; De Ravin SS; Elliott E; Ziegler JB;
Pediatr Allergy Immunol; 2008 Jun; 19(4):298-302. PubMed ID: 18221464
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy outpaces haplo for SCID-X1.
Kohn DB
Blood; 2015 Jun; 125(23):3521-2. PubMed ID: 26045591
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993.
Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
J Immunol; 2008 Nov; 181(9):5817-27. PubMed ID: 18941169
[No Abstract] [Full Text] [Related]
14. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation.
Puck JM;
J Allergy Clin Immunol; 2007 Oct; 120(4):760-8. PubMed ID: 17931561
[TBL] [Abstract][Full Text] [Related]
15. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
[TBL] [Abstract][Full Text] [Related]
16. Towards safe therapy for immunodeficiency.
Tsai SQ
Nat Biomed Eng; 2017 Dec; 1(12):937-938. PubMed ID: 31015711
[No Abstract] [Full Text] [Related]
17. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.
Mazzolari E; Forino C; Guerci S; Imberti L; Lanfranchi A; Porta F; Notarangelo LD
J Allergy Clin Immunol; 2007 Oct; 120(4):892-9. PubMed ID: 17825895
[TBL] [Abstract][Full Text] [Related]
18. [Hematopoietic stem cell transplantation in children with primary immunodeficiencies].
Kelecić J; Rajić L; Tjesić-Drinković D
Acta Med Croatica; 2009 Jun; 63(3):255-8. PubMed ID: 19827355
[TBL] [Abstract][Full Text] [Related]
19. [Disseminated BCG infection revealing X-linked severe combined immunodeficiency].
Marchand I; Mahé E; Clérici T; Saiag P; Chevallier B
Ann Dermatol Venereol; 2008; 135(8-9):587-90. PubMed ID: 18789295
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation in multiple sclerosis.
Rogojan C; Frederiksen JL
Acta Neurol Scand; 2009 Dec; 120(6):371-82. PubMed ID: 19785643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
